Role of Primary Care in Management of Heart Failure Preserved Ejection Fraction (HFpEF): A Literature Review
Abstract
Heart failure with preserved ejection fraction (HFpEF) is a non-communicable disease with the prevalence increasing globally. HFpEF has signs and symptoms of typical heart failure, with EF >50%, and structural heart disease or raised BNP. Primary care has an important role to prevent the progression of HFpEF. In this study, we review the importance of primary care in HFpEF management and the gaps with the newest ESC guideline in real practice. The challenges in the diagnosis of HFpEF result in treatment delayed or disease progression. Since there is a new drug has been added to the newest guideline, prior guideline adherence in primary care is suboptimal. Communication is the key to bridging the physician and expert. More epidemiological study of HFpEF in the specific region would be a starting point in an effort for adapting standardized guidelines and this requires a health system with appropriate resources and incentives.
Keywords: HFpEF, primary care, disease prevention, guideline, communication.
Keywords:
HFpEF, primary care, disease prevention, guideline, communicationDOI
https://doi.org/10.22270/jddt.v12i3-S.5508References
Macinko J, Dourado I, Guanais FC. Chronic Diseases, Primary Care and Health Systems Performance Diagnostics, Tools and Interventions. Inter-American Development Bank 2011:189.
Taylor AL. Heart Failure in Woman. Current Heart Failure Reports 2015; 12:187-195. https://doi.org/10.1007/s11897-015-0252-x
Tromp J, Teng TH, Tay WT, et al. Heart failure with preserved ejection fraction in Asia. European Journal of Heart Failure 2019; 21:23-36. https://doi.org/10.1002/ejhf.1227
Callender T, Woodward M, Roth G, et al. Heart Failure Care in Low- and Middle-Income Countries: A Systematic Review and Meta-Analysis. Plos Medicine 2014; 11:8. https://doi.org/10.1371/journal.pmed.1001699
Hussey PS, Schneider EC, Rudin RS, et al. Continuity and the Costs of Care for Chronic Disease. JAMA Internal Medicine 2014; 174:5. https://doi.org/10.1001/jamainternmed.2014.245
Komajda M, Cowie MR, Tavazzi L, et al. Physicians' guideline adherence is associated with better prognosis in outpatients with heart failure with reduced ejection fraction: the QUALIFY international registry. European Journal of Heart Failure 2017; 19:1414-1423. https://doi.org/10.1002/ejhf.887
Dunlay SM, Roger VL, Redfield MM. Epidemiology of heart failure with preserved ejection fraction. Nature Reviews Cardiology 2017; 14: 591-602. https://doi.org/10.1038/nrcardio.2017.65
Pfeffer MA, Shah AM, Borlaug BA. Heart Failure with Preserved Ejection Fraction In Perspective. Circulation Research 2019; 1598-1611. https://doi.org/10.1161/CIRCRESAHA.119.313572
Forsyth F, Mant J, Taylor CJ, et al. Optimising Management of Patients with Heart Failure with Preserved Ejection Fraction in Primary Care (OPTIMISE- HFpEF): rationale and protocol for a multi-method study. BJGP Open 2019. https://doi.org/10.3399/bjgpopen19X101675
McDonagh TA, Metra M, Adamo M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. European Heart Journal 2021; 42:3599-3726. https://doi.org/10.1093/eurheartj/ehab368
Hossain MZ, Chew-Graham CA, Sowden E, et al. Challenges in the management of people with heart failure with preserved ejection fraction (HFpEF) in primary care: A qualitative study of general practitioner perspectives. Chronic Illness 2021; 1-16. https://doi.org/10.1177/1742395320983871
Meer PVD, Gaggin HK, Dec GW. ACC/AHA Versus ESC Guidelines on Heart Failure. Journal of American College of Cardiology 2019; 23. https://doi.org/10.1016/j.jacc.2019.03.478
Heath R. Johnsen HK. Strain WD, et al. Emerging Horizons in Heart Failure with Preserved Ejection Fraction: The Role of SGLT2 Inhibitors. Diabetes Therapy 2022; 13:241-250. https://doi.org/10.1007/s13300-022-01204-4
Reyes EB, Ha JW, Firdaus I, et al. Heart Failure Across Asia: Same Healthcare Burden but Differences in Organization of Care. International Journal of Cardiology 2016; 223:163-167. https://doi.org/10.1016/j.ijcard.2016.07.256
Wagdy K, Nagy S. EMPEROR-Preserved: SGLT2 inhibitors breakthrough in the management of heart failure with preserved ejection fraction. Globar Cardiology Science and Practice 2021; 19. https://doi.org/10.21542/gcsp.2021.17
Butler J, Usman MS, Khan MS, et al. Efficacy and Safety of SGLT2 Inhibitors in Heart Failure: Systematic Review and Meta-analysis. ESC Heart Failure 2020; 7:3298-3309. https://doi.org/10.1002/ehf2.13169
Harada K, Kario K. The dawn of a new era of targeted therapies for heart failure with preserved ejection fraction (HFpEF). Hypertension Research 2022; 45:164-166. https://doi.org/10.1038/s41440-021-00799-8
Stewart S, Stewart AR, Waite L, et al. Out with the Old and In with the New: Primary Care Management of Heart Failure with Preserved Ejection Fraction. Cardiac Failure Review 2022; 8:04. https://doi.org/10.15420/cfr.2021.27
Visseren VLJ, Mach F, Smulders YM, et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. European Heart Journal 2021); 42:3227-3337. https://doi.org/10.1093/eurheartj/ehab484
Savarese G, Lund LH. Global Public Health Burden of Heart Failure. Cardiac Failure Review 2017; 3(1):7-11. https://doi.org/10.15420/cfr.2016:25:2
Kenchaiah S, Vasan RS. Heart Failure in Women - Insights from the Framingham Heart Study. Cardiovascular Drugs and Therapy 2015; 29:377-390. https://doi.org/10.1007/s10557-015-6599-0
Paneni F, Costantino S, Hamdani N. Regression of left Ventricular Hypertrophy with SGLT2 Inhibitors. European Heart Journal 2020; 41:3433-3436. https://doi.org/10.1093/eurheartj/ehaa530
Published
Abstract Display: 527 
PDF Downloads: 558 PDF Downloads: 40 How to Cite
Issue
Section
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
How to Cite
.